Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
D 113.66 0.16% 0.18
ABT closed up 0.16 percent on Thursday, March 28, 2024, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 17
*** please verify all earnings dates ***
13 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 0.16%
Slingshot Bearish Bearish Swing Setup 1.94%
Multiple of Ten Bullish Other 1.94%
Oversold Stochastic Weakness 1.94%
Lower Bollinger Band Walk Weakness 3.32%
Multiple of Ten Bullish Other 3.32%
Lower Bollinger Band Touch Weakness 3.32%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 20 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
Rose Above Previous Day's High about 24 hours ago
Up 1 ATR 2 days ago
60 Minute Opening Range Breakout 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Cancer Life Sciences Pain Infectious Diseases Diabetes Eye Pharmaceutical Products Inflammation Hypertension Influenza Glucose Lipid Hematology Lab Testing Vascular Disease Diagnostic Products Thyroid Fertility Health Care Products Blood Glucose Monitoring Cataracts Immunoassay Nutritional Products Contact Lens Fever Irritable Bowel Syndrome Dyslipidemia Influenza Vaccine Generic Pharmaceutical Vascular Products Cataract Surgery Generic Pharmaceuticals Data Management Software Lasik Lens Care Products Cholestasis Hypothyroidism Intrahepatic Cholestasis

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 121.64
52 Week Low 89.2488
Average Volume 5,906,746
200-Day Moving Average 105.80
50-Day Moving Average 115.14
20-Day Moving Average 116.08
10-Day Moving Average 112.33
Average True Range 2.03
RSI (14) 45.95
ADX 31.64
+DI 19.96
-DI 27.44
Chandelier Exit (Long, 3 ATRs) 115.54
Chandelier Exit (Short, 3 ATRs) 115.21
Upper Bollinger Bands 124.00
Lower Bollinger Band 108.16
Percent B (%b) 0.35
BandWidth 13.65
MACD Line -1.19
MACD Signal Line -0.62
MACD Histogram -0.5703
Fundamentals Value
Market Cap 197.32 Billion
Num Shares 1.74 Billion
EPS 3.26
Price-to-Earnings (P/E) Ratio 34.87
Price-to-Sales 4.87
Price-to-Book 5.18
PEG Ratio 26.92
Dividend 2.08
Dividend Yield 1.83%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 115.30
Resistance 3 (R3) 115.23 114.63 115.02
Resistance 2 (R2) 114.63 114.21 114.66 114.93
Resistance 1 (R1) 114.14 113.95 114.39 114.21 114.84
Pivot Point 113.54 113.54 113.66 113.57 113.54
Support 1 (S1) 113.05 113.12 113.30 113.12 112.48
Support 2 (S2) 112.45 112.86 112.48 112.39
Support 3 (S3) 111.96 112.45 112.30
Support 4 (S4) 112.03